Progyny, Inc. Form 8-K Summary
Business Context and Reporting Period
Progyny, Inc. (PGNY) filed a Current Report on Form 8-K on February 26, 2026. The filing announces the financial results for the fiscal quarter and full year ended December 31, 2025. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) and a supplemental presentation (Exhibit 99.2) for detailed data. The text of this 8-K does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the incorporated exhibits for these figures.
Material Changes
The filing text does not contain specific data regarding material changes in financial performance compared to prior periods. Such comparisons are contained within the referenced press release and supplemental presentation.
Guidance, Outlook, and Risks
The filing incorporates by reference a press release and supplemental earnings presentation which typically contain management commentary, forward-looking guidance, and risk factors. The 8-K text itself does not detail specific outlooks, contingencies, or unusual items, noting only that the information in the exhibits is not deemed "filed" under Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2025 revenue and earnings figures.
- Examine Exhibit 99.2 (Supplemental Presentation) for detailed margin analysis, cash flow statements, and debt levels.
- Verify forward-looking guidance and any updated risk factors disclosed in the press release.
- Confirm the company's status as an emerging growth company and any related accounting election disclosures.